细化菌尿作为尿道成形术后并发症风险因素:识别致病菌
单机构两位术者回顾性分析2003年8月至2021年6月1611例尿道成形术患者,23.2%术前存在显著菌尿,7.9%发生90天Clavien-Dindo≥2级并发症。革兰阴性杆菌(14.2%,P=0.01)和肠球菌属(15.1%,P=0.03)与并发症风险升高相关,而革兰阳性球菌、革兰阳性杆菌、混合生长和念珠菌无显著关联。
要点
- 革兰阴性杆菌菌尿患者90天并发症率14.2%,显著高于其他病原体。
- 肠球菌属菌尿患者并发症率15.1%,与术后并发症风险升高相关。
- 革兰阳性球菌、混合生长和念珠菌菌尿患者并发症风险未显著增加。
核心结论
- 尿道成形术后菌尿相关并发症的主要驱动因素是革兰阴性杆菌和肠球菌属。
- 菌尿与其他微生物相关的患者可能可以继续进行尿道成形术而不增加术后并发症风险。
研究设计与样本
- 单机构、两位术者回顾性审查,纳入2003年8月至2021年6月接受尿道成形术的患者。
- 术前菌尿显著定义为混合培养≥10^8 CFU/L或可识别微生物≥10^6 CFU/L。
- 采用描述性统计总结结果,卡方检验分析90天并发症(Clavien≥2级)与临床特征/细菌的关联。
主要发现
- 1611例患者中,23.2%(373例)存在显著术前菌尿。
- 最常见病原体包括凝固酶阴性葡萄球菌18.5%(69例)、混合生长15.8%(59例)、大肠埃希菌10.7%(40例)和肠球菌属14.2%(53例)。
- 7.9%(128/1611)发生显著90天并发症(Clavien-Dindo≥2级)。
- 革兰阴性杆菌(包括大肠埃希菌、假单胞菌属、克雷伯菌属、沙雷菌属、柠檬酸杆菌属、无色杆菌属、寡养单胞菌属和摩根菌属)与术后并发症率升高相关(14.2%;P=0.01),肠球菌属亦相关(15.1%;P=0.03)。
- 革兰阳性球菌(7.9%;P=0.97)、革兰阳性杆菌(11.8%;P=0.47)、混合生长(5.1%;P=0.54)和念珠菌(16.7%;P=0.27)与并发症无显著关联;细菌浓度升高(P=0.44)或菌株数量(P=0.08)与并发症风险增加无关。
临床怎么用
- 作者认为,菌尿相关并发症的主要驱动因素是革兰阴性杆菌和肠球菌属。
- 作者认为,菌尿与其他微生物相关的患者可能可以继续进行尿道成形术而不增加术后并发症风险。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine which bacteria are associated with an increased risk of 90-day complications after urethroplasty. Preoperative bacteriuria is associated with an increased risk of complications after urethroplasty. However, it remains unclear which specific micro-organisms are the primary drivers of this morbidity. METHODS: A single-institution, 2-surgeon retrospective review was performed on patients undergoing urethroplasty from 08/2003 to 06/2021. Preoperative bacteriuria was considered significant when the patient had a mixed culture with ≥108 CFU/L or an identifiable micro-organism with ≥106 CFU/L. Descriptive statistics were used to summarize the results and chi-square was used to determine the association between 90-day complications (Clavien ≥2) and clinical characteristics/bacteria. RESULTS: Out of 1611 patients, 23.2% (373) had significant preoperative bacteriuria. The most common pathogens included coagulase-negative staphylococcus 18.5% (69), mixed growth 15.8% (59), Escherichia coli 10.7% (40), and Enterococcus 14.2% (53). 7.9% (128/1611) experienced a significant 90-day complication (Clavien-Dindo ≥2). Gram-negative bacilli including E coli, Pseudomonas sp, Klebsiella sp, Serratia sp, Citrobacter sp, Achromobacter sp, Stenotrophomonas sp, and Morganella sp were associated with higher rates of postoperative complications (14.2%; P = .01) as well as Enterococcus sp (15.1%; P = .03). However, gram-positive cocci (7.9%; P = .97), gram-positive bacilli (11.8%; P = .47), mixed growth (5.1%; P = .54) and Candida (16.7%; P = .27) were not. Neither escalating concentrations of bacteria (P = .44) or number of strains (P = .08) were associated with increased risk of complications. CONCLUSION: The main driver of bacteriuria-related complications after urethroplasty are gram-negative bacilli and Enterococcus sp. Patients with bacteriuria related to other micro-organisms can likely proceed with urethroplasty without increased risk of postoperative complications.
引用
- Calvo CI, Hoy N, Rourke KF, et al. Refining Bacteriuria as a Risk Factor for Complications After Urethroplasty: Identifying the Culprit. Urology. 2024. PMID: 38354912. doi:10.1016/j.urology.2024.01.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。